Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
The International Journal of Biological Markers
|
July 7, 2000
EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts
P N Span, N Grebenchtchikov, J Geurts-Moespot, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia
M R Feneley, P N Span, J A Schalken, et al.
Clinical Chemistry
|
April 28, 2001
Assay for hexosamine pathway intermediates (uridine diphosphate-N-acetyl amino sugars) in small samples of human muscle tissue
P N Span, M J Pouwels, A J Olthaar, et al.
Journal of Endocrinological Investigation
|
January 5, 2002
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice
F H van Enckevort, C G Sweep, P N Span, et al.
European Journal of Radiology
|
April 10, 2013
Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients
R M Mann, P Bult, H W M van Laarhoven, et al.
International Journal of Oncology
|
July 16, 2004
Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients
P Manders, L V A M Beex, V C G Tjan-Heijnen, et al.
European Cytokine Network
|
January 10, 2002
Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice
F H van Enckevort, C G Sweep, P N Span, et al.
The Lancet. Oncology
|
October 5, 2007
Early identification of treatment resistance in GTN
N E van Trommel, L F A G Massuger, P N Span, et al.
The Journal of Urology
|
February 26, 1999
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate
P N Span, M C Völler, A G Smals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2018
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
D Głodzik, C Purdie, I H Rye, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
The International Journal of Biological Markers
|
July 7, 2000
EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts
P N Span, N Grebenchtchikov, J Geurts-Moespot, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia
M R Feneley, P N Span, J A Schalken, et al.
Clinical Chemistry
|
April 28, 2001
Assay for hexosamine pathway intermediates (uridine diphosphate-N-acetyl amino sugars) in small samples of human muscle tissue
P N Span, M J Pouwels, A J Olthaar, et al.
Journal of Endocrinological Investigation
|
January 5, 2002
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice
F H van Enckevort, C G Sweep, P N Span, et al.
European Journal of Radiology
|
April 10, 2013
Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients
R M Mann, P Bult, H W M van Laarhoven, et al.
International Journal of Oncology
|
July 16, 2004
Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients
P Manders, L V A M Beex, V C G Tjan-Heijnen, et al.
European Cytokine Network
|
January 10, 2002
Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice
F H van Enckevort, C G Sweep, P N Span, et al.
The Lancet. Oncology
|
October 5, 2007
Early identification of treatment resistance in GTN
N E van Trommel, L F A G Massuger, P N Span, et al.
The Journal of Urology
|
February 26, 1999
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate
P N Span, M C Völler, A G Smals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2018
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
D Głodzik, C Purdie, I H Rye, et al.
Page
of 5